Ukulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
A Randomized Controlled Trial of Ukulele Playing Compared to Music Listening to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
1 other identifier
interventional
29
1 country
1
Brief Summary
Over the past 10 years, the rates of multiple sclerosis (MS) have nearly doubled in the United States. This chronic, neuroinflammatory, and neurodegenerative disease is most often diagnosed between the ages of 20-40. Cognitive impairment effects up to 70% of people with MS (PwMS) and has a detrimental impact on mental health, social connections, and employment. Further, up to 50% of PwMS also struggle with depression. Numerous cognitive rehabilitation programs are available to address cognitive impairment, but few interventions have simultaneous effects on cognition and emotional well-being. Music interventions have potential to fill this gap. Brain imaging studies on music and emotion show that music can modulate activity in the brains structures that are known to be crucially involved in emotion. Further, music engages areas of the brain that are involved with paying attention, making predictions, and updating events in our memory. The purpose of this study is to determine the feasibility of an online musical training intervention (MTI) for PwMS and explore the potential effect on cognition, psychosocial, and functional well-being compared to an active control group (music listening (ML)). The specific aims are to: 1) determine the feasibility and acceptability of delivering the MTI virtually over three months to PwMS; 2) evaluate the effect of the MTI on cognitive functioning (processing speed, working memory, cognitive flexibility, response inhibition), psychosocial (anxiety, depression, stress, quality of life, self-efficacy) and functional (insomnia) well-being compared to ML; and 3) (exploratory aim) to utilize non-invasive neuroimaging to determine if pre-intervention brain activity predicts post-intervention cognitive functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2023
CompletedStudy Start
First participant enrolled
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedMarch 13, 2025
November 1, 2024
1.5 years
February 16, 2023
March 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Intervention Feasibility
Feasibility will be evaluated by tracking the percentage of participants screened and enrolled.
Immediately post-intervention
Intervention Feasibility
Feasibility will be evaluated by tracking the average number of participants enrolled monthly.
Immediately post-intervention
Intervention Feasibility
Protocol adherence will be evaluated by recording the average number of modules completed by participants.
Immediately post-intervention
Intervention Acceptability
Acceptability will be evaluated with semi-structured interview questions to understand the participant's perception of MTI delivery and content and the perceived impact.
Immediately post-intervention
Secondary Outcomes (10)
Mean Change from Baseline in Anxiety Scores at 12 weeks and 16 weeks
Immediately post-intervention and 1-month post-intervention
Mean Change from Baseline in Depression Scores at 12 weeks and 16 weeks
Immediately post-intervention and 1-month post-intervention
Mean Change from Baseline in Stress Scores at 12 weeks and 16 weeks
Immediately post-intervention and 1-month post-intervention
Mean Change from Baseline in Self-Efficacy Scores at 12 weeks and 16 weeks
Immediately post-intervention and 1-month post-intervention
Mean Change from Baseline in Quality of Life Scores at 12 weeks and 16 weeks
Immediately post-intervention and 1-month post-intervention
- +5 more secondary outcomes
Study Arms (2)
Musical Training Intervention
EXPERIMENTALParticipants randomized to this arm receive a 12-week intervention to teach them how to play the ukulele. The ukulele is a very manageable instrument to learn and requires less hand dexterity than other stringed instruments. Each week participants will follow the musical training intervention (MTI) protocol that provides instruction on how to tune, hold, and strum the ukulele and play basic chords. To practice the chords, they will also learn popular songs (e.g., Chain of Fools, Three Little Birds, Happy Birthday, Don't Worry Be Happy, and Stand by Me). Participants will be instructed to follow each session outlined weekly and asked to practice the instrument for at least 30 minutes, 5 days a week. They will be given a paper and digital version of the MTI protocol. A member of our research team will call the participants weekly to answer any questions about the MTI protocol.
Music Listening
ACTIVE COMPARATORParticipants randomized to this arm will be asked to listen to their preferred music for at least 30 minutes, 5 days a week. A member of our research team will call them every week to answer any questions they have about the ML protocol. They will be asked to record their experience in a practice log.
Interventions
The Music Training Intervention (MTI) entails 12-weeks of online instruction to learn to play the ukulele. Participants will be taught the basic information on how to handle and hold the ukulele, musical chords, and popular songs. They will be instructed to play at least 30-minutes a day, five days a week.
Participants randomized to this arm will be asked to listen to their preferred music for at least 30 minutes, 5 days a week. A member of our research team will call them every week to answer any questions they have about the ML protocol. They will be asked to record their experience in a practice log.
Eligibility Criteria
You may qualify if:
- Diagnosed with multiple sclerosis (relapsing remitting, secondary progression, primary progressive)
- Diagnosed more than 6 months prior to starting study
- Self-reported cognitive impairment as assessed by having at least 5 problems "sometimes" or more often on the Perceived Deficits Questionnaire
- Read, write, and understand English
- Access to computer and zoom
You may not qualify if:
- Diagnosed with another neurological condition that causes cognitive impairment
- MS exacerbation within the last 30 days
- Unable to travel to The University of Texas at Austin for fNIRS data collection
- Professional musician (primary source of income)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas at Austin
Austin, Texas, 78712, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolyn Phillips, PhD
University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 16, 2023
First Posted
March 31, 2023
Study Start
March 27, 2023
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
March 13, 2025
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share